MCID/Low disease activity state workshop: Summary, recommendations and research agenda
Wells, G., Anderson, J., Boers, M., Felson, D., Heilberg, T., Hewlett, S., Johnson, K., Kirwan, J. R., Lassere, M., Robinson, V., Shea, B., Simon, L., Stran, V., Van Riel, P. and Tugwell, P. (2003) MCID/Low disease activity state workshop: Summary, recommendations and research agenda. Journal of Rheumatology, 30 (5). pp. 1115-1118. ISSN 0315-162X Available from: http://eprints.uwe.ac.uk/705
Full text not available from this repository
Publisher's URL: http://www.jrheum.org/content/30/5/1115.abstract
The OMERACT 6 Minimal Clinically Important Difference/Low Disease Activity Workshop was organized with the aim of meeting the many challenges that exist in determining a low disease activity in rheumatoid arthritis (RA). This article presents an overview of that workshop, including results of the voting, a summary of associated discussions, recommendations, and a proposed research agenda.